Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Chinese biotech firms are rapidly gaining global prominence through innovative drugs and partnerships, nearly matching the U.S. pipeline.
Chinese biotech firms are gaining global prominence through innovative drug development and partnerships.
Recent successes include LaNova Medicines' deal with Merck & Co. and Legend Biotech's FDA-approved CAR-T therapy.
China's drug pipeline now represents over a third of the global total, nearly matching the US.
The government's support and the use of AI in drug development are driving this growth, as firms focus on unmet medical needs and secure international approvals.
4 months ago
7 Articles
Articles
Further Reading
You have 4 free stories remaining this month. Subscribe anytime for unlimited access.